Related Experiment Videos
[Lung involvement in systemic lupus erythematosus (SLE)--own experience]
Magdalena Martusewicz-Boros1, Elzbieta Wiatr, Monika Płodziszewska
1III Kliniki Gruźlicy i Chorób Płuc, Instytutu Gruźlicy i Chorób Płuc w Warszawie. m.martusewicz@igichp.edu.pl
Pneumonologia I Alergologia Polska
|August 1, 2002
Summary
Pulmonary manifestations are common in systemic lupus erythematosus (SLE), often presenting as interstitial lung disease or pleural involvement. Early diagnosis of these lung conditions in SLE patients is crucial for effective management.
Area of Science:
- Rheumatology
- Pulmonology
- Internal Medicine
Background:
- Systemic lupus erythematosus (SLE) frequently affects the lungs, presenting diverse clinical and pathological patterns.
- Pulmonary involvement can be an early or primary manifestation of SLE, posing diagnostic challenges.
Observation:
- A study observed 11 patients (9 female, 2 male) with pulmonary manifestations of SLE over 18 years.
- The mean age of patients was 47.7 years; no cases of drug-induced SLE were noted.
Findings:
- Interstitial lung diseases (7/11) and pleural involvement (5/11) were the most common presentations.
- Airway disease (reduced FEV1%VC) occurred in 3 cases, and "shrinking lung" syndrome in 1 case.
- Pulmonary hypertension was associated with interstitial lung disease or vasculitis in SLE patients.
Implications:
- Recognizing varied pulmonary manifestations is key for timely SLE diagnosis and treatment.
- Understanding these lung patterns can improve patient outcomes in SLE.
- Further research into specific mechanisms of SLE-induced lung disease is warranted.